{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:42:28Z","timestamp":1777614148507,"version":"3.51.4"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.1001\/jamadermatol.2022.1113","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T15:04:22Z","timestamp":1651676662000},"page":"704","source":"Crossref","is-referenced-by-count":4,"title":["Diagnosis of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors"],"prefix":"10.1001","volume":"158","author":[{"given":"Azael","family":"Freites-Martinez","sequence":"first","affiliation":[{"name":"Oncodermatology Clinic, Hospital Ruber Juan Bravo, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"11","key":"dle220004r1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamadermatol.2021.3676","article-title":"Clinicopathologic characteristics and response to treatment of persistent chemotherapy-induced alopecia in breast cancer survivors.","volume":"157","author":"Bhoyrul","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"5","key":"dle220004r2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jaad.2012.02.010","article-title":"Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events version 4.0.","volume":"67","author":"Chen","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"dle220004r3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","article-title":"Endocrine therapy-induced alopecia in patients with breast cancer.","volume":"154","author":"Freites-Martinez","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"5","key":"dle220004r4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jaad.2018.03.056","article-title":"Hair disorders in cancer survivors.","volume":"80","author":"Freites-Martinez","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"dle220004r5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jamadermatol.2018.5071","article-title":"Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia.","volume":"155","author":"Freites-Martinez","year":"2019","journal-title":"JAMA Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2791462\/jamadermatology_freitesmartinez_2022_le_220004_1654530060.90558.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T15:02:54Z","timestamp":1655305374000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2791462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2022.1113","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}